The aim of the present study was therefore first to investigate whether methylation of TRIM9 promoter is associated with its gene expression in breast cancer cells, and second to clarify the clinicopathological characteristics of TRIM9 methylated breast tumors. This evidence concerns the gene TRIM9 and breast cancer.